Durect Corporation (DRRX)

0.891 -0.09  -9.08%  May 17, 8:00PM
Add to Watchlists Create an Alert

Durect Corporation R&D Expense Quarterly:

4.789M for March 31, 2013
View Full Chart

Durect Corporation R&D Expense Quarterly Chart

    Durect Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 4.789M
    Dec. 31, 2012 4.904M
    Sept. 30, 2012 4.745M
    June 30, 2012 4.982M
    March 31, 2012 5.634M
    Dec. 31, 2011 7.013M
    Sept. 30, 2011 8.452M
    June 30, 2011 8.708M
    March 31, 2011 9.88M
    Dec. 31, 2010 9.447M
    Sept. 30, 2010 8.142M
    June 30, 2010 9.204M
    March 31, 2010 9.421M
    Dec. 31, 2009 9.267M
    Sept. 30, 2009 7.598M
    June 30, 2009 7.866M
    March 31, 2009 9.903M
    Dec. 31, 2008 8.456M
    Sept. 30, 2008 11.42M
    June 30, 2008 9.898M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    DRRX R&D Expense Quarterly Benchmarks

    Companies
    Acura Pharmaceuticals 2.026M
    Pain Therapeutics 1.183M
    Pfizer 1.80B

    DRRX R&D Expense Quarterly Rankings

    Overall 88th percentile
    849 of 7593
    Sector 63rd percentile
    240 of 650 in Healthcare
    Industry 47th percentile
    34 of 65 in Drug Manufacturers - Specialty & Generic

    DRRX R&D Expense Quarterly Range, Past 5 Years

    Minimum 4.745M Sep 2012
    Maximum 11.42M Sep 2008
    Average 7.987M